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Clostridium difficile-associated disease is increasing in incidence and is costly to treat. Our understanding of how this organism
senses its entry into the host and adapts for growth in the large bowel is limited. The small-molecule second messenger cyclic
diguanylate (c-di-GMP) has been extensively studied in Gram-negative bacteria and has been shown to modulate motility, bio-
film formation, and other processes in response to environmental signals, yet little is known about the functions of this signaling
molecule in Gram-positive bacteria or in C. difficile specifically. In the current study, we investigated the function of the second
messenger c-di-GMP in C. difficile. To determine the role of c-di-GMP in C. difficile, we ectopically expressed genes encoding a
diguanylate cyclase enzyme, which synthesizes c-di-GMP, or a phosphodiesterase enzyme, which degrades c-di-GMP. This strat-
egy allowed us to artificially elevate or deplete intracellular c-di-GMP, respectively, and determine that c-di-GMP represses mo-
tility in C. difficile, consistent with previous studies in Gram-negative bacteria, in which c-di-GMP has a negative effect on myr-
iad modes of bacterial motility. Elevated c-di-GMP levels also induced clumping of C. difficile cells, which may signify that C.
difficile is capable of forming biofilms in the host. In addition, we directly quantified, for the first time, c-di-GMP production in a
Gram-positive bacterium. This work demonstrates the effect of c-di-GMP on the motility of a Gram-positive bacterium and on
aggregation of C. difficile, which may be relevant to the function of this signaling molecule during infection.
Cyclic diguanylate (3=,5=-cyclic diguanylic acid) (c-di-GMP) isa second messenger utilized exclusively by prokaryotes to ef-
fect global changes in cellular physiology (45). c-di-GMP has been
implicated in changes to the cellular envelope in multiple species
and mediates the transition from planktonic growth to biofilm
formation in many Gram-negative bacteria. c-di-GMP augments
biofilm formation by increasing the production of adhesins and
extracellular matrix components through altered gene regulation
(21, 36, 37, 56, 67, 68) and posttranslational modifications (10,
73). Conversely, c-di-GMP inhibits motility by reducing the tran-
scription or translation of flagellar genes (1, 2, 26, 29, 35), imped-
ing pilus assembly (24, 28), or inhibiting the rotation of assembled
flagella (4, 8, 40, 49). In addition to regulating biofilm formation
and motility, c-di-GMP coordinates cell-wide responses to life-
style transitions such as entry into stationary phase (60), expres-
sion of virulence genes (22, 30, 64, 69), resistance to antibiotics
and host immune responses (22, 33), and cell developmental shifts
(13, 41, 70).
The level of c-di-GMP in the cell is controlled by three types of
enzymes. c-di-GMP is synthesized from two molecules of GTP by
diguanylate cyclases (DGCs) containing a GGDEF domain,
named for a conserved motif in the active site (46, 50, 56). c-di-
GMP is hydrolyzed by two distinct families of phosphodiesterases
(PDEs), known as EAL and HD-GYP domains, which are also
named for conserved amino acid residues (6, 9, 48, 51, 65). These
are highly modular domains, often coupled to a variety of known
sensory and/or regulatory domains, and can occur in multiple
proteins within one organism (17, 18). Transcriptional and post-
transcriptional control of DGCs and PDEs could allow meticulous
temporal and spatial regulation of c-di-GMP in the cell.
The Gram-positive, spore-forming, obligate anaerobe Clos-
tridium difficile causes nosocomial infections that are often recur-
rent and sometimes fatal. Annual treatment costs are estimated to
be in excess of $3 billion in the United States alone (11, 38). C.
difficile is transmitted between individuals in the form of metabol-
ically inactive spores that germinate in the gut to produce vegeta-
tively growing bacilli. How C. difficile mediates the adaptation to
the intestinal environment and production of cytotoxins is only
beginning to be understood. Little is known about how the organ-
ism adheres to the intestinal wall and colonizes the host. C. difficile
produces flagella that allow swimming motility, which in many
bacterial pathogens contributes to pathogenesis. A recent study
showed that C. difficile flagellar mutants (fliC and fliD mutants)
colonize Caco-2 intestinal epithelial cells in higher numbers than
the isogenic wild-type strain (12), while FliC and FliD were dis-
pensable for virulence in hamsters. However, evidence from in
vitro and other animal studies indicates that the flagellum is in-
volved in cellular adherence (66), and human patients with C.
difficile-associated disease produce antibodies against C. difficile
flagellar proteins, indicating that flagella are produced in vivo (66).
Furthermore, flagella isolated from C. difficile clinical isolates in-
volved in recent outbreaks show various patterns of protein gly-
cosylation, suggesting that flagellar function and regulation may
contribute to differences in transmissibility and virulence ob-
served between strains (71).
Biofilm formation by C. difficile, while not yet demonstrated in
vitro (44), has been proposed to occur during colonization of in-
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testinal surfaces. Thick mats of C. difficile have been observed in
association with sites of severe inflammation in an infected animal
model (31), suggesting that biofilm production occurs in vivo.
Other bacteria, including commensal species and pathogens, are
known to form multi- or single-species biofilms in the mamma-
lian intestine (16, 32, 72). C. difficile may benefit from passive or
active interactions with commensal biofilms or may have distinct
mechanisms for development of biofilms in the host.
The sequenced genome of Clostridium difficile 630 encodes 37
different proteins predicted to play a role in c-di-GMP metabo-
lism (52). This is far more than are found in other clostridial
genomes such as those of C. perfringens or C. botulinum, which
encode 9 and 16 predicted DGCs/PDEs, respectively (55, 58). The
enzymatic functionality of several of these C. difficile DGCs and
PDEs has been confirmed by expressing them heterologously in
Vibrio cholerae, where they result in phenotypes consistent with
elevated or lowered levels of intracellular c-di-GMP (5). However,
the roles that DGCs and PDEs play in C. difficile biology and in
motility in particular are unknown. The identification of a c-di-
GMP-binding riboswitch, Cd1, immediately upstream of a flagel-
lar operon strongly suggests that c-di-GMP is involved in regulat-
ing flagellar gene expression and cellular motility (63). While Cd1
can regulate the expression of a heterologous reporter gene in
response to c-di-GMP (63), neither this riboswitch nor c-di-GMP
has been shown to regulate motility or any other process in C.
difficile.
In this study, we determined the role of c-di-GMP in regulating
the motility of C. difficile. Organisms with multiple DGCs and
PDEs exert spatial, temporal, and posttranslational regulation in
order to prevent cross talk between pathways, but these signaling
networks are often at least partially redundant, and the contribu-
tion of any given gene may be masked in a knockout analysis (27,
30, 53). Ectopic expression of a DGC or PDE raises or lowers the
global intracellular level of c-di-GMP, respectively, and provides a
way to assess the roles of this signaling molecule in regulating
pathways of interest (2, 64). In order to apply this approach to the
question of C. difficile flagellar motility, we constructed a plasmid
for inducible expression of DGC and PDE genes in C. difficile.
Here we demonstrate that c-di-GMP negatively regulates motility
of C. difficile by repressing expression of flagellar genes. Further-
more, we observed that c-di-GMP promotes aggregation of C.
difficile cells, which implies the ability of C. difficile to form bio-
films. This study provides the first direct evidence that C. difficile
synthesizes c-di-GMP which affects its cellular processes, such as
motility and biofilm formation.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plas-
mids used in this study are listed in Table S1 in the supplemental material.
C. difficile strains were grown in BHIS medium (59) at 37°C in an anaer-
obic chamber with an atmosphere of 90% N2, 5% CO2, and 5% H2. Media
for growth of C. difficile were supplemented with 10 g/ml thiamphenicol
(BHIS-Tm) and/or 100 g/ml kanamycin, as appropriate. Escherichia coli
strains were propagated in Luria Bertani (LB) medium or on LB agar
plates containing 50 g/ml ampicillin and/or 10 g/ml chloramphenicol,
as needed, at 37°C under aerobic conditions.
Plasmid and strain construction. All restriction enzymes and DNA
polymerase (Phusion) were purchased from New England BioLabs. Oli-
gonucleotide sequences used in this study are listed in Table S2 in the
supplemental material. Genomic DNA from C. difficile strain 630
(GenBank accession number AM180355) (52) was used as the template in
all PCRs. For expression in E. coli, CD1420 (dccA) was amplified with
primers dccAF and dccAR, CD1515 (pdcA) with primers pdcAF and
pdcAR, and the EAL domain of CD1515 (pdcA-EAL) with primers
pdcAFb and pdcAR. A mutant allele of dccA in which the GGDEF active
site is mutated to AADEF (dccAmut) was generated using splicing by over-
lap extension PCR (SOE-PCR), with primers dccAF and dccAgaR gener-
ating the upstream fragment and primers dccAgaF and dccARb generat-
ing the downstream fragment. All three resulting fragments were digested
with KpnI and PstI and cloned into similarly digested pBAD33 (for dccA
and dccAmut) or pMMBneo (for pdcA and pdcA-EAL) (39). The plasmids
were confirmed by PCR using gene-specific and plasmid-specific primers
(67EHF and 67EHR). The plasmids were introduced by electroporation
into E. coli BL21.
For expression of relevant genes in C. difficile, we first generated a
vector for inducible expression of these genes. The promoter from the cpr
locus (34) was amplified from CD630 genomic DNA using primers PcprF
and PcprR. The PCR products were digested with EcoRI and KpnI and
cloned into similarly digested pMC123 (34), yielding pMC-Pcpr (see Fig.
S1 in the supplemental material). This plasmid was confirmed by PCR
with primers pUCmcsF and m13r.
The dccA, dccAmut, and pdcA-EAL genes were cloned into pMC-Pcpr.
For dccA and dccAmut, the native ribosomal binding sites (RBS) were re-
tained with primers dccAbamHI and dccApstI. For the truncated pdcA-
EAL, an RBS was introduced using the forward primer pdcAEbamHI,
which was paired with primer pdcApstI. Each of the 3 fragments was
digested with BamHI and PstI and cloned into similarly digested pMC-
Pcpr. The plasmids were confirmed by PCR using primers pUCmcsF and
m13r and named pDccA, pDccAmut, and pPdcA-EAL. These plasmids,
along with the pMC-Pcpr vector, were each transformed by electropora-
tion into HB101(pRK24). The pRK24 plasmid is a broad-host-range
plasmid RP4 derivative that mobilizes IncP oriT plasmids. The
HB101(pRK24) plasmid donor strains were mated with C. difficile strain
630, resulting in transfer of pDccA, pDccAmut, and pPdcA-EAL into C.
difficile. Transconjugants were selected on BHIS-Tm supplemented with
kanamycin and appeared after 48 h of growth at 37°C. C. difficile strains
containing the desired plasmids were screened by PCR using primers
pUCmcsF and m13r to confirm the presence of a plasmid with an insert of
the correct size and using primers tcdBF and tcdBR to confirm isolation of
C. difficile. At least two isolates were obtained for each conjugation (see
Fig. S1 in the supplemental material). Using the same conjugation and
screening methods, the pDccA, pDccAmut, and pPdcA-EAL plasmids were
moved into C. difficile strain R20291.
Protein purification. E. coli expression strains were grown at 37°C to
an optical density at 600 nm (OD600) of 0.1 to 0.15 (1-cm path length), at
which point the temperature was dropped to 25°C and expression was
induced with 1 mM isopropyl--D-thiogalactopyranoside (IPTG) for 16
h. Cells were lysed by sonication in His6 buffer (10 mM Tris-HCl [pH 7.8],
300 mM NaCl, 50 mM NaH2PO4, 10% glycerol, 1 mM phenylmethyl-
sulfonyl fluoride [PMSF]). Lysates were clarified by centrifugation and
purified on HisPure Ni-nitrilotriacetic acid (Ni-NTA) resin (Thermo Sci-
entific) according to the manufacturer’s protocol. DccA was dialyzed
overnight against 75 mM Tris (pH 7.8), 250 mM NaCl, 25 mM KCl, 10
mM MgCl2, and 30% glycerol and stored at 20°C. PdcA and PdcAEAL
were stored at 4°C and used for enzymatic assays within 5 days of purifi-
cation.
In vitro enzymatic assays. Purified DccA and the DccA mutant were
assayed for DGC activity using [-32P]GTP as the substrate as described
previously (65). Purified WspR (21) was included as a positive control;
buffer only was used as the negative control. The reaction mixtures were
treated with 1 l calf intestinal phosphatase (CIP) (New England BioLabs)
for 30 min at 37°C to remove the phosphate radiolabel from unincorpo-
rated GTP. Aliquots (0.5 l) taken before and after CIP treatment were
analyzed by thin-layer chromatography as described previously (65). Full-
length PdcA, which contains a GGDEF domain with an active-site se-
quence, suggesting that it lacks DGC activity, was nonetheless assayed for
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DGC activity as described above but in reaction buffer containing 5 mM
CaCl2 to inhibit PDE activity of the EAL domain.
PdcA and PdcA-EAL were assayed for PDE activity by incubating the
purified enzymes with 32P-labeled c-di-GMP as described previously (65).
The radiolabeled c-di-GMP substrate was synthesized and purified as de-
scribed previously (43, 65). Buffer-only reaction mixtures were used as a
negative control. Aliquots (0.5 l) of the reaction mixtures were analyzed
as described above for the DGC assays.
Measurements of intracellular c-di-GMP levels. c-di-GMP was mea-
sured as described previously (3), with the following modifications. C.
difficile strains were grown in 50 ml BHIS-Tm, with or without nisin
induction (1 g/ml), to an OD600 of 0.6; the optical densities of the cul-
tures at time of collection were recorded. Dilutions were plated to deter-
mine the number of CFU extracted. The bacteria were collected by cen-
trifugation and washed once with TE buffer (10 mM Tris [pH 7.5], 1 mM
EDTA, pH 8), and then nucleotides were extracted with methanol
(MeOH)-acetonitrile-distilled water (dH2O) (40:40:20) plus 0.1 N formic
acid as described previously (3). Samples (50 l out of 200 l total) were
analyzed by high-pressure liquid chromatography (HPLC)-tandem mass
spectrometry (MS/MS) (3). The amount of intracellular c-di-GMP was
determined by fitting the peak intensity to a standard curve obtained by
analyzing serial dilutions of c-di-GMP and dividing the total amount of
c-di-GMP extracted by the total intracellular volume of bacteria extracted.
The intracellular volume of bacteria extracted was calculated by multiply-
ing the volume of one bacterial cell by the number of cells extracted, which
was based on CFU counts. The volume of one bacterial cell was estimated
as a cylinder with a radius of 0.37 m and a length of 2.235 m, using
ImageJ software to measure cell dimensions from electron micrographs.
Figure S3 in the supplemental material shows the measurements obtained
from 100 bacterial cells either parallel (for length determination) or per-
pendicular (for radius determination) to the slide surface. For cell length
determination, cells with lengths of greater than 4 m were presumed to
be dividing and were excluded from the analysis.
Motility assays. Individual colonies were inoculated using sterile
toothpicks into 0.3% agar plates containing BHIS-Tm and nisin at 0, 0.01,
0.1, or 1 g/ml nisin. Plates were incubated at 37°C in an anaerobic cham-
ber for up to 96 h. The diameters of the motility swarms were measured
every 24 h. The mean diameters and standard deviations are reported.
RNA isolation and real-time PCR. RNA was isolated as described
previously from C. difficile cultures grown in BHIS-Tm, without or with 1
g/ml nisin, to an OD600 of 1.0 (34). cDNA samples were prepared from
200 ng RNA using random hexamers and the Tetro cDNA synthesis kit
(Bioline). Real-time PCRs were done with 2 ng cDNA template using the
SensiMix SYBR and fluorescein kit (Bioline). Primers (see Table 2 in the
supplemental material) were designed using the PrimerQuest tool from
IDT DNA technologies and detected transcripts of flgB, flgM, fliA, and
codY. At least three biological replicates were analyzed. The rpoC tran-
script was measured and used for normalization (34). The raw threshold
cycle (CT) values for rpoC were equivalent in all RNA samples tested, and
thus rpoC was not differentially expressed in any of the strains. Controls
with no reverse transcriptase were included for all templates and all
primer sets. The data were analyzed using the CT method and are
expressed as the fold change in normalized transcript relative to the aver-
age value for the induced vector control.
Detection of flagellin. Flagellins were assayed as described previously
(71). Briefly, C. difficile strains were grown to an OD600 of 1.0. Culture
samples were vortexed vigorously for 3 min, and then cells and large
debris were removed by centrifugation. The supernatants were analyzed
by SDS-PAGE (12%) and Coomassie blue staining. The band correspond-
ing to the 26-kDa protein suspected to be flagellin was identified by using
ABI 4800 matrix-assisted laser desorption ionization–time of flight
(MALDI TOF/TOF) mass spectrometry at the University of North Caro-
lina Michael Hooker Proteomics Center.
Assessment of aggregation. Strains were grown in BHIS-Tm contain-
ing 0 or 1 g/ml nisin. After 18 h of growth at 37°C, the optical densities at
600 nm of the unperturbed cultures were measured. The cultures were
vortexed vigorously to disrupt the aggregates, and the optical densities
were measured again. The assay was performed multiple times, each with
three biological replicates. For electron microscopy, the strains were
grown as described above, centrifuged for 5 min at 700  g, suspended in
150 mM sodium phosphate buffer (pH 7.4), and mixed 1:1 with 4% glu-
taraldehyde in 150 mM sodium phosphate buffer. The cells were dehy-
drated through increasing concentrations of ethanol and dried using car-
bon dioxide as the transition solvent in a Samdri-795 critical-point dryer
(Tousimis Research Corporation, Rockville, MD). Coverslips were
mounted on aluminum stubs with carbon adhesive tabs, followed by sput-
ter coating with a 5-nm thickness of gold-palladium alloy (60 Au-40 Pd)
in a Hummer X sputter coater (Anatech USA, Union City, CA). Images
were taken using a Zeiss Supra 25 field emission scanning electron micro-
scope (FESEM) operating at 5 kV, with a working distance of 5 mm and a
10-m aperture (Carl Zeiss SMT Inc., Peabody, MA).
For quantification of aggregation, C. difficile with pDccA or empty
vector was grown in BHIS-Tm with 1 g/ml nisin and then viewed by
differential interference contrast (DIC) microscopy at a magnification of
40. ImageJ was used to identify and count cell aggregates in photographs
of 20 randomly selected fields of view for each sample. Aggregates were
defined as two or more cells contacting along the long axis or three or
more cells contacting at the poles (to exclude cells undergoing division).
RESULTS
Identification of active C. difficile enzymes. The physiological
responses of C. difficile to c-di-GMP are unknown, making char-
acterization of the second-messenger-based regulatory network
problematic. Not only is targeted mutagenesis of genes not trivial
in this organism, but the large number of C. difficile genes pre-
dicted to synthesize or hydrolyze c-di-GMP further complicates
attempts to determine their roles, as the effect of disrupting any
given gene could be masked by the function of multiple, partially
redundant orthologues. To begin to determine the functions of
c-di-GMP in C. difficile, we decided to ectopically express an active
c-di-GMP synthetase or phosphodiesterase to increase or decrease
intracellular c-di-GMP, respectively. We could then examine the
cellular responses to changes in the global c-di-GMP concen-
tration, an approach that has been successfully utilized in V.
cholerae (2, 64).
C. difficile encodes 37 putative c-di-GMP DGCs and PDEs (17,
18, 52). CD1420, which encodes the smallest DGC, was previously
demonstrated to be a catalytically active enzyme (5). The CD1420
gene product is predicted to be a soluble cytoplasmic protein, with
no other sensory or regulatory domains present to modulate its
activity (Fig. 1A). Furthermore, CD1420 lacks an I site (5), which
should allow unchecked synthesis of c-di-GMP. Thus, we chose to
overexpress CD1420, which we have named dccA (diguanylate
cyclase from Clostridium A), in C. difficile, and we anticipated that
this would result in elevated intracellular c-di-GMP levels.
There is no single-domain PDE encoded in the C. difficile ge-
nome. Eighteen of the 19 EAL-domain containing proteins also
contain a GGDEF domain, though in all but one of these cases the
GGDEF domain is predicted to be inactive (5). In addition, all but
three of the EAL domain proteins have predicted transmembrane
domains. The presence of the EAL domain in conjunction with an
inactive GGDEF domain or other sensory or regulatory domains
could render the protein inactive under certain experimental con-
ditions or could obscure the effect of overexpression. Therefore,
we chose to express a truncated phosphodiesterase, consisting
only of an EAL domain, to deplete c-di-GMP in C. difficile. We
focused on CD1515, which is predicted to encode a soluble PAS-
c-di-GMP regulation in Clostridium difficile
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GGDEF-EAL fusion protein. This protein, which we have named
PdcA (phosphodiesterase from Clostridium A), has a poorly con-
served GGDEF motif that is unlikely to retain any catalytic activ-
ity, and a well-conserved EAL domain (Fig. 1A). PdcA is expected
to be an active c-di-GMP PDE, as its ectopic expression in a het-
erologous host, Vibrio cholerae, resulted in reduced biofilm for-
mation and increased motility phenotypes as expected from re-
duced intracellular c-di-GMP (5).
To confirm the catalytic activities of DccA, full-length PdcA,
and the EAL domain of PdcA (PdcA-EAL), we expressed His6-
tagged alleles of dccA, pdcA, and pdcA-EAL in E. coli, purified the
recombinant proteins, and assayed enzymatic activity in vitro.
DccA and the positive control WspR, a DGC from Pseudomonas
aeruginosa (21), were tested for DGC activity. Both DccA and
WspR produced c-di-GMP when incubated with radiolabeled
GTP, demonstrating that both proteins can function as diaguany-
late cyclases (Fig. 1B). The ability of DccA to synthesize c-di-GMP
was abolished when the GGDEF motif was mutated to AADEF,
confirming that DGC activity relies on the GGDEF active site.
PdcA and PdcA-EAL were tested for c-di-GMP phosphodiesterase
activity. Both the full-length and truncated proteins quickly hy-
drolyzed c-di-GMP to linear pGpG (Fig. 1C), confirming PDE
function and demonstrating that truncation did not affect enzy-
matic activity of the EAL domain. Indeed, the EAL domain
seemed to have higher activity for the secondary hydrolysis of
pGpG to GMP, suggesting that the PAS or inactive GGDEF do-
main may inhibit activity of the full-length protein (Fig. 1C). To
avoid any of the experimental or analytical complications that
such inhibition might cause in vivo, PdcA lacking the PAS and
GGDEF domains, PdcA-EAL, was used for subsequent experi-
ments.
Development of an inducible overexpression system for use
in C. difficile. Few systems are available for inducible expression
of genes in C. difficile (15). Therefore, in order to express dccA and
pdcA-EAL in C. difficile, we developed a plasmid-based system for
the inducible expression of these genes. This plasmid, pMC-Pcpr,
derives from pMC123, which is stably maintained extrachromo-
somally in C. difficile (34) and uses the C. difficile cpr promoter to
drive expression of genes (see Fig. S1A in the supplemental mate-
rial). The clostridial cpr promoter controls the expression of a
putative ABC transporter system that enables C. difficile to survive
exposure to the cationic antimicrobial peptides nisin and gallider-
min (34). The operon under the control of this promoter is up-
regulated 10- to 20-fold in response to sublethal concentrations of
nisin but is not significantly impacted by a number of other
stresses, including heat, acid, or oxygen stress (14), confirming
that it is induced specifically by nisin and is not part of a general
stress response. We cloned dccA, the mutant dccA allele (dccAmut),
and pdcA-EAL into pMC-Pcpr to create the expression plasmids
pDccA, pDccAmut, and pPdcA-EAL, respectively. The resulting
plasmids, as well as pMC-Pcpr, were introduced into C. difficile
strain 630 through conjugation. Thiamphenicol-resistant transcon-
jugants were confirmed to contain the desired plasmids and to be C.
difficile, as shown by the presence of the chromosomal tcdB gene (see
Fig. S1B in the supplemental material). All strains were found to grow
equivalently and maximally in BHIS-Tm containing up to 1 g/ml
nisin, with no differences in doubling times observed (data not
shown). At nisin concentrations of 5 g/ml or higher, the growth
rates of all strains were slightly impeded, so all subsequent experi-
ments were performed using at most 1 g/ml nisin.
To test whether growth in the presence of nisin induces expres-
sion of the genes placed under the control of the cpr promoter, we
performed quantitative reverse transcription-PCR (qRT-PCR)
analysis of the dccA and pdcA-EAL transcripts in cultures grown in
the presence and absence of 1 g/ml nisin. In the absence of nisin,
the level of dccA transcript in the C. difficile pDccA strain was
indistinguishable from that in the control strain carrying the
empty vector. When nisin was present in the growth medium, the
dccA transcript was induced approximately 6-fold (Fig. 2A).
The same results were observed for the dccAmut allele. In the C.
difficile pPdcA-EAL strain, the pdcA-EAL transcript was slightly
elevated even in the absence of nisin. However, induction with
nisin caused a further 7-fold increase in transcript (Fig. 2A).
Having confirmed that transcription of dccA, dccAmut, and
pdcA-EAL is induced by nisin in the respective strains, we further
determined the effect of expression on the intracellular c-di-GMP
level. The c-di-GMP content of C. difficile with pDccA, pDccAmut,
pPdcA-EAL, or the empty vector, each grown with or without 1
g/ml nisin, was determined by HPLC-tandem mass spectrome-
try as described previously (3). The estimated intracellular con-
centration of c-di-GMP in the experimental control strain was
determined to be 15 to 50 nM. However, growth of the pDccA
FIG 1 Domain architectures and enzymatic activities of the enzymes used in
this study. (A) Domain structures of DccA (CD1420) and PdcA (CD1515).
The actual amino acid sequences in the GGDEF and EAL motifs are shown
above the relevant domain. (B) Purified DccA and DccA with GGDEF-to-
AADEF mutations (DccAmut), as well as the WspR DGC (positive control),
were assayed in vitro for DGC activity using [-32P]GTP as the substrate.
Reaction products were analyzed before () and after () treatment with CIP
using thin-layer chromatography (TLC). (C) Purified PdcA and its EAL do-
main alone (PdcA-EAL) were assayed in vitro for c-di-GMP phosphodiesterase
activity using 32P-labeled c-di-GMP as the substrate. At the indicated times,
reaction products were analyzed by TLC. The identities of spots in panels B and
C were assigned based on characteristic relative mobilities, as described previ-
ously (47).
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strain in the presence of nisin resulted in over a 1,000-fold increase
in intracellular c-di-GMP compared to that in the control strain
(Fig. 2B). Although there were minor fluctuations in the intracel-
lular c-di-GMP concentration in the PdcA and DccAmut expres-
sion strains relative to the control strain, none of the strains
showed differences similar to that for induction of DccA. As the
samples were near the limit of detection of c-di-GMP (5 to 10
nM), with the exception of DccA induction, it is possible that these
differences are due to noise and are not biologically relevant. Sur-
prisingly, induction of pdcA-EAL expression did not detectably
reduce the intracellular c-di-GMP content in C. difficile.
Manipulating c-di-GMP levels affects swimming motility of
C. difficile. Elevated c-di-GMP levels are associated with inhibited
cellular motility in multiple flagellated species, due to altered gene
expression and flagellum assembly and/or function. The presence
of a c-di-GMP riboswitch upstream of a flagellar operon suggested
that c-di-GMP regulates swimming motility of C. difficile (63),
though this has not been demonstrated. We used a soft agar plate
assay to monitor and quantify the effect of c-di-GMP on motility,
and we observed movement of C. difficile through soft agar which
was not impaired by the presence of 1 g/ml nisin (Fig. 3). In the
C. difficile 630 strain background, without nisin, DccA and the
enzymatically inactive DccAmut had no impact on motility, while
induction of active DccA dramatically decreased motility. The
presence of pPdcA-EAL had no significant effect on motility of C. dif-
ficile 630, whether or not nisin was present (Fig. 2A).
To address potential issues due to strain specificity, these plas-
mids were also introduced into the epidemic C. difficile isolate
R20291, where they similarly conferred thiamphenicol resistance
and were confirmed by PCR (data not shown). As seen in C. dif-
ficile 630, induction of dccA expression with nisin resulted in a
dramatic decrease in motility through soft agar (see Fig. S4 in the
supplemental material). While expression of pPdcA-EAL in
R20291 led to a statistically significant increase in motility, the
effect was small and independent of the presence of nisin.
Induction with 1 g/ml nisin was useful for the identification
of motility phenotypes regulated by c-di-GMP but resulted in in-
tracellular c-di-GMP concentrations well above those measured
in C. difficile or other bacteria (57). To determine whether inter-
mediate levels of c-di-GMP can affect motility, dccA expression
was induced in C. difficile 630 pDccA by the addition of 0, 0.01, 0.1,
or 1 g/ml nisin. The intracellular concentration of c-di-GMP
increased with increasing concentrations of nisin in the growth
medium (Fig. 4A); as little as 0.01 g/ml nisin resulted in a signif-
icant increase in c-di-GMP. Furthermore, the motility of C. diffi-
cile in soft agar medium decreased with increasing intracellular
c-di-GMP, and reduced motility could be observed in C. difficile
with 100 to 150 nM c-di-GMP (Fig. 4B).
c-di-GMP impedes transcription of flagellar genes. Previous
work has shown that a c-di-GMP riboswitch, named Cd1, lies
upstream of the flgB open reading frame and presumably controls
expression of flgB and the downstream flagellar genes (63). A tran-
FIG 2 Modulation of intracellular c-di-GMP by ectopic expression of DccA,
DccAmut, and PdcA-EAL. (A) Induction of DccA, DccAmut, and PdcA-EAL
gene expression by addition of nisin to the growth medium. The levels of the
transcripts for the genes indicated at the top were measured by qRT-PCR in the
relevant strains grown with (dark gray) or without (light gray) 1 g/ml nisin.
Data were analyzed using the CT method and are expressed as the average
fold change in transcript compared to that of the induced vector control. (B)
Alteration of intracellular c-di-GMP upon expression of DccA, DccAmut, and
PdcA-EAL genes. HPLC was used to measure intracellular c-di-GMP in strains
containing the indicated plasmids and grown with (dark gray) or without
(light gray) 1 g/ml nisin. Three biological replicates were analyzed. The con-
centrations shown were calculated as described in Materials and Methods. In
panels A and B, data were analyzed by one-way analysis of variance (ANOVA)
and Dunnett’s posttest, with comparisons to the induced vector control (*, P 
0.05).
FIG 3 c-di-GMP negatively regulates motility of C. difficile 630. C. difficile
strains with pDccA, pDccAmut, pPdcA-EAL, or empty vector were assayed for
motility in BHIS-Tm with 0.3% agar and supplemented with 0 or 1 g/ml
nisin. The swarm diameters, indicative of the motility of each strain, were
measured daily for 96 h. (A) Representative motility plates after 48 h of incu-
bation at 37°C. (B) Quantitative measurements of motilities of strains grown
with or without nisin, after 48 h. Shown are the means and standard deviations
of the swarm diameters from four independent experiments. Asterisks indicate
statistically significant differences (P  0.05 by one-way ANOVA and Dun-
nett’s posttest, comparing data to those for the induced vector control.).
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scriptional fusion of the Cd1-containing flgB promoter to a lacZ
reporter gene showed that this riboswitch functions as an “off
switch” in response to c-di-GMP. Furthermore, in vitro transcrip-
tion assays demonstrated that addition of c-di-GMP to the reac-
tion mixture led to the appearance of a truncated flagellar tran-
script, indicating that regulation of flagellar gene expression
occurs at the level of transcription rather than translation. These
data strongly suggest that c-di-GMP inhibits flagellar gene expres-
sion in C. difficile. To test this, C. difficile with pDccA, pDccAmut,
pPdcA-EAL, or empty vector was grown in the presence or ab-
sence of nisin, and the levels of flagellar gene transcripts in each of
these strains were measured by qRT-PCR. We chose three flagellar
genes to examine for expression by qRT-PCR: flgB, which is im-
mediately downstream of the Cd1 riboswitch; fliA, which is near
the end of the flgB operon and encodes a sigma factor (	70) pre-
dicted to activate flagellar gene expression; and flgM, a gene at the
beginning of a second, upstream flagellar operon not predicted to
be directly controlled by Cd1. In all cases, increasing intracellular
c-di-GMP by inducing dccA expression with nisin dramatically
reduced the levels of flgB, fliA, and flgM mRNAs (Fig. 5A); expres-
sion of the dccAmut allele had no effect on flgB, fliA, or flgM tran-
script levels. Furthermore, rpoC transcript levels were equivalent
among all strains grown with or without nisin, and the level of
codY transcript was unaffected by induction of dccA expression
and increased c-di-GMP synthesis. Therefore, dccA expression
does not have a global negative effect on transcription. Neither the
induction of pdcA-EAL nor dccAmut impacted flagellar gene tran-
script levels (data not shown), consistent with the wild-type levels
of motility of the respective strains.
Isolation of extracellular proteins from induced and unin-
duced cultures to enrich for flagellin also showed that cells over-
expressing dccA had no appreciable levels of flagellin subunit (Fig.
5B). Induction of dccA expression resulted in the loss of a protein
of approximately 30 kDa. This protein band, when excised from
the control sample and analyzed by mass spectrometry, contained
C. difficile flagellin as the most abundant protein (data not
shown). Again consistent with the wild-type motility of C. difficile
pPdcA-EAL, induction of pdcA-EAL had no discernible effect on
the production or secretion of flagellin (Fig. 3A).
Artificially elevating c-di-GMP levels causes aggregation of
cultured cells. In numerous other bacterial species, increases in
c-di-GMP not only impair various types of motility but in many
cases upregulate the production of factors that contribute to bio-
film production (45). While biofilm formation by C. difficile has
not been directly demonstrated and we and others have been un-
able to observe C. difficile biofilms on abiotic surfaces, it has been
proposed that C. difficile may produce such structures on intesti-
nal surfaces (reference 44 and data not shown). We observed that
C. difficile containing pDccA formed visible aggregates when the
DGC was induced and intracellular c-di-GMP increased. Upon
reaching optical densities of above 
0.8 in broth culture, cells
overexpressing dccA began to aggregate and sediment in the cul-
ture tube (Fig. 6A). Over time, the optical density of undisturbed
cultures expressing induced DccA decreased compared to that of
all other strains (Fig. 6B). The aggregates could be dispersed by
vigorous vortexing, after which the C. difficile pDccA strain had an
optical density comparable to that of the other cultures (Fig. 6B).
The optical densities of the cultures containing aggregates, upon
vortexing, increased at the same rate as for the other cultures (data
not shown), indicating that the aggregated cells remained viable
and continued to divide. Further analysis of these aggregates by
scanning electron microscopy showed that in cultures of C. diffi-
FIG 4 Induction by different concentrations of nisin results in graded effects
on motility of C. difficile 630. (A) HPLC-MS/MS was used to determine the
amount of c-di-GMP in C. difficile with pDccA grown in BHIS-Tm with 0,
0.01, 0.1, or 1 g/ml nisin. Three biological replicates were analyzed, and data
were normalized to the calculated cell volume extracted, with means and stan-
dard deviations shown. Asterisks indicate statistically significant differences
from the uninduced sample (P  0.05 by unpaired t test). (B) C. difficile strains
with empty vector or pDccA were assayed for motility in BHIS-Tm with 0.3%
agar and supplemented with the indicated concentrations of nisin (g/ml).
Shown are the means and standard deviations of the swarm diameters after
48 h of incubation at 37°C, from four independent experiments. Asterisks
indicate statistically significant differences in motility (P  0.05 by two-way
ANOVA and Bonferroni’s posttest).
FIG 5 c-di-GMP represses production of flagella by regulating transcription
of flagellar genes in C. difficile 630. (A) Using qRT-PCR, transcript levels of
rpoC, flgB, flgM, fliA, and codY in the indicated strains grown with or without
1 g/ml nisin were measured. At least three biological replicates were analyzed.
Data were analyzed using the CT method with rpoC as the reference tran-
script and normalized to the induced vector control. Asterisks indicate a P
value of 0.05 as determined by one-way ANOVA and Dunnett’s posttest,
comparing values to that for the induced vector control. (B) The amount of
flagellar protein produced was determined by SDS-PAGE of extracellular pro-
teins of uninduced and induced cultures of the indicated strains. The indicated
band was determined to be flagellin by mass spectrometry.
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cile pDccA grown with nisin, the cells formed large aggregates
visibly bound together by fibrous networks (Fig. 6C). However,
the aggregates were completely absent in the vector control strain
grown under the same conditions. The control strain contained
primarily free-living cells. Using DIC microscopy, we determined
the number of aggregates present in stationary-phase cultures of
C. difficile with pDccA or empty vector, both grown in the pres-
ence of nisin. The vector control strain contained a negligible
number of aggregates, all of which consisted of 3 cells or fewer (see
Fig. S5 in the supplemental material). In the pDccA strain there
were numerous aggregates present, many of which contained 4 or
more bacteria. We propose that this c-di-GMP-dependent aggre-
gation phenotype, promoted in this case by the artificial manipu-
lation of c-di-GMP, represents a possible mechanism for biofilm
production in the host.
DISCUSSION
C. difficile infection is a widespread and costly public health prob-
lem whose prevalence and severity will likely increase in the com-
ing decades, as an aging population spends more time in hospitals
and nursing homes. Characterizing the mechanisms by which C.
difficile regulates gene expression while in the host intestinal tract,
the only known natural environment in which the bacterium has
been shown to grow vegetatively, is critical to understanding the
basis for its pathogenicity. This study focused on c-di-GMP, be-
cause relatively little is known about the roles of c-di-GMP in
Gram-positive bacteria and in C. difficile in particular. Only a few
studies have investigated the function of c-di-GMP in Gram-pos-
itive species, and to our knowledge, c-di-GMP has never been
directly measured in a Gram-positive bacterium. Genetic evi-
dence indicates that in Streptomyces coelicolor c-di-GMP regulates
the development of mycelia and the production of the antibiotic
actinorhodin (70). In Staphylococcus aureus, a protein with a de-
generate GGDEF domain regulates biofilm formation and protein
A production, but this is independent of the GGDEF protein’s
enzymatic activity and cellular c-di-GMP levels (23, 54). Our cur-
rent work is the first study to directly quantify c-di-GMP produc-
tion in a Gram-positive bacterium, demonstrate the effect of c-di-
GMP on the motility of a Gram-positive species, and show a
function for c-di-GMP in C. difficile.
We estimated the intracellular concentration of c-di-GMP in
C. difficile to be 15 to 50 nM during exponential growth in rich
medium. Compared with that in other bacteria, this is a relatively
low concentration of c-di-GMP. Using the data obtained by Simm
et al., the concentration of c-di-GMP ranges from 0.1 M in E. coli
to 2 M in V. cholerae (57). Similarly, we typically observe that the
concentration of c-di-GMP in V. cholerae is 1 to 2 M (unpub-
lished results). However, it is clear that C. difficile has the capacity
to generate very high intracellular concentrations of c-di-GMP, as
overproduction of DccA increased c-di-GMP levels to approxi-
mately 50 M. Interestingly, this high level of c-di-GMP did not
result in the toxicity that has been observed in E. coli (50). In
addition, while the numerous GGDEF and EAL domain proteins
encoded in the C. difficile genome have been assessed for enzy-
matic function in a heterologous organism (5), the importance of
c-di-GMP in the biology of C. difficile has not been investigated
previously. We showed that c-di-GMP represses the motility of C.
difficile as it does in other bacteria and that intracellular c-di-GMP
is inversely related to motility. Importantly, reduced motility of C.
difficile 630 can be observed when the global intracellular c-di-
GMP level is 
100 nM, which represents a 2- to 6-fold increase
compared to c-di-GMP levels in wild-type cells grown in vitro.
While the physiological levels of c-di-GMP of C. difficile in the
host bowel are unknown, our results suggest that relatively small
changes in c-di-GMP can alter motility. Determining the natural
range of c-di-GMP concentrations in C. difficile during growth in
its natural environment will be critical to understanding the im-
pact of c-di-GMP regulation in vivo.
FIG 6 Elevated c-di-GMP induces aggregation of C. difficile 630 cells. (A) Representative cultures grown in BHIS-Tm with 1 g/ml nisin. The arrow shows
sedimented aggregates in the C. difficile pDccA culture. (B) Quantification of cell aggregation by optical density measurement. The optical densities (600 nm) of
the cultures were determined pre- and postvortexing. White bars are for uninduced cultures before vortexing, black bars are for induced cultures before
vortexing, light gray bars are for uninduced cultures after vortexing, and dark gray bars are for induced cultures after vortexing. Assays were performed in
triplicate. The asterisk indicates a P value of 0.05 as determined using two-way ANOVA and Bonferroni’s posttest, comparing each strain to the induced vector
control. (C) Scanning electron microscopy of C. difficile pDccA and the vector control strain grown in BHIS-Tm containing 1 g/ml nisin. The magnification
used is shown under each panel.
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Regulation of C. difficile motility occurs at least in part at the
level of flagellar gene expression. This result was anticipated based
on the characterization of the Cd1 riboswitch upstream of the
operon led by flgB. Interestingly, c-di-GMP also repressed the
level of mRNA for flgM, which is carried in a second flagellar
operon not under the direct control of Cd1. Both operons contain
genes encoding structural and regulatory elements required for
proper flagellar function. It is likely that a gene product of the flgB
operon regulates expression of the second flagellar operon. For
example, expression of fliA, which is presumably cotranscribed
with flgB and encodes a RNA polymerase sigma factor (	D), is also
repressed by c-di-GMP. In other bacteria, including Bacillus sub-
tilis, FliA is required for flagellar gene expression and motility (7,
25, 62). In C. difficile, repression of fliA transcription by c-di-GMP
and the Cd1 riboswitch may in turn reduce transcription of the
flgM operon. Such a mechanism would link transcription of both
operons to the level of c-di-GMP in the cell, consistent with our
expression data (Fig. 6A).
The pPdcA-EAL fragment was enzymatically active in vitro.
However, there were no detectable differences in the intracellular
levels of c-di-GMP in the pPdcA-EAL strain compared to the vec-
tor control strain, nor did we observe increased transcription of
flgB, fliA, or flgM. It is possible that our inability to detect de-
creased c-di-GMP in the pPdcA-EAL strain is due to “buffering”
that maintains a minimum level of c-di-GMP in the cell. For ex-
ample, attempts to reduce c-di-GMP by ectopic expression of
PdcA-EAL may lead to increased transcription or activity of one or
more of the 18 putative DGCs encoded in the C. difficile genome.
Conversely, the expression or activity of PDEs may be downregu-
lated. Either possibility could serve to maintain a minimum level
of c-di-GMP in the cell.
There are nearly 20 C. difficile strains for which the full or
partial genomes are available. These genomes are highly variable
and contain an unusually high number of mobile elements, 11%
of the C. difficile 630 genome (52). In order to rule out strain-
specific effects, we introduced the empty vector, pDccA, pDccAmut,
and pPdcA-EAL into C. difficile isolate R20291, which is consid-
ered an epidemic isolate (61). The R20291 strain, of the 027 ri-
botype, differs genotypically and phenotypically from strain 630
(ribotype 012) (61), including differences in the battery of c-di-
GMP signaling factors encoded (5). For example, several c-di-
GMP metabolic genes present in 630 are absent or divergent in the
R20291 genome (5). As in C. difficile 630, induction of DccA se-
verely inhibited motility of R20291, and this effect was dependent
upon an intact GGDEF motif. These results indicate that regula-
tion of motility of C. difficile by c-di-GMP is conserved within the
species. Both 630 and R20291 contain the Cd1 riboswitch up-
stream of the flgB operon, while some C. difficile strains do not (5).
It would be interesting to determine if and how c-di-GMP regu-
lates flagellar swimming in C. difficile strains lacking the Cd1 ri-
boswitch. The importance of motility for adherence, colonization,
and virulence is uncertain (12, 66), but the production of flagella
during infection (42) and variation in flagellar protein glycosyla-
tion among strains (71) suggest that flagella may affect immune
recognition of the bacteria or variation in virulence between
strains.
While C. difficile has not been demonstrated to form biofilms
on abiotic surfaces in vitro, it has been suggested that C. difficile
forms biofilms in the gut to maintain long-term colonization of
the bowel (44). The unexpected observation that C. difficile with
elevated c-di-GMP forms visible aggregates suggests that c-di-
GMP may augment a biofilm-related process in this bacterium.
The ability of C. difficile to aggregate in this manner may be linked
to host tissue damage in the mouse model (31). The aggregates
observed in cultures of bacteria with high c-di-GMP levels consist
of clumps apparently assisted by long, thin fibers. These fibers are
approximately 10 nm in thickness, which is consistent with the
size of pili. The C. difficile 630 genome contains type IV pilus gene
clusters (52), and there is evidence that pili are produced during
colonization of the hamster (19). This raises the interesting possi-
bility that c-di-GMP may upregulate production of pili to aid in
colonization. Future studies are aimed at determining the compo-
sition of these fibers.
The role of c-di-GMP in inversely regulating motility and ag-
gregation in C. difficile, as in many other bacteria, suggests that
c-di-GMP may be a key player in pathogenesis. The large number
of c-di-GMP regulatory and sensory factors encoded by C. difficile
further suggests that this bacterium may carefully modulate the
level of c-di-GMP in the cell. The limitation of our strategy of
manipulating c-di-GMP by ectopic expression of a DGC and PDE
is that it does not address the natural control of intracellular c-di-
GMP and its downstream regulatory targets. Future studies will be
necessary to understand the complex spatial and temporal regu-
lation of and by c-di-GMP, as well as to identify additional targets
of c-di-GMP regulation.
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